MML Investors Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.97M | Buy |
|
|||||
|
2025
Q2 | $5.82M | Buy |
|
|||||
|
2025
Q1 | $3.49M | Buy |
|
|||||
|
2024
Q4 | $2.53M | Buy |
|
|||||
|
2024
Q3 | $849K | Buy |
|
|||||
|
2024
Q2 | $710K | Sell |
|
|||||
|
2024
Q1 | $623K | Buy |
|
|||||
|
2023
Q4 | $756K | Buy |
|
|||||
|
2023
Q3 | $532K | Sell |
|
|||||
|
2023
Q2 | $620K | Buy |
|
|||||
|
2023
Q1 | $533K | Buy |
|
|||||
|
2022
Q4 | $573K | Buy |
|
|||||
|
2022
Q3 | $354K | Sell |
|
|||||
|
2022
Q2 | $1.45M | Buy |
|
|||||
|
2022
Q1 | $1.51M | Buy |
|
|||||
|
2021
Q4 | $1.53M | Buy |
|
|||||
|
2021
Q3 | $1.55M | Buy |
|
|||||
|
2021
Q2 | $1.3M | Buy |
|
|||||
|
2021
Q1 | $1.02M | Buy |
|